| Next 10 |
GlobeNewswire News Releases and Press Releases
GlobeNewswire news releases, related news releases, and press releases on the OTC, NASDAQ and NYSE markets.
-
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year cardiovascular event risk compared with statins alone (p<0.0001) - - Patients considere...
-
Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart failure and new heart failure requiring hospitalization with higher achieved serum EPA levels Amarin to Webcast Discussion of Data Presented at AC...
-
DENVER, May 14, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Assure Holdings Corp. (TSXV: IOM; OTCQB: ARHH), the CONDENSED INTERIM CONSOLIDATED STATEMENT OF INCOME/(LOSS) table was omitted and the financial tables were not aligned with the appropriat...
-
OTTAWA, Ill., May 14, 2021 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for Ottawa Savings Bank, FSB (the “Bank”), today announced that the Bank has submitted an application to the Illinois Department of Financial an...
-
LORDSTOWN, Ohio, May 14, 2021 (GLOBE NEWSWIRE) -- Lordstown Motors Corp. (Nasdaq: RIDE), (“Lordstown Motors”), a leader in electric light duty trucks focused on the commercial fleet market, today announced that it will reschedule the release of its first quarter 2021 financial...
-
BOSTON, May 14, 2021 (GLOBE NEWSWIRE) -- The New Ireland Fund, Inc. (NYSE: IRL) announced today the preliminary results of its tender offer, which expired at 11:59 p.m. Eastern Time on Thursday, May 13, 2021. The purchase price of properly tendered shares is 98% of the net asset v...
-
EMPAVELI, the first targeted C3 therapy, is approved for use in adults with PNH who are: Treatment naïve Switching from C5 inhibitor Soliris® (eculizumab) Switching from C5 inhibitor Ultomiris® (ravulizumab) EMPAVELI was superior ...
-
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, May 14, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. ( TSX-V:WMD ) ( OTCQX:WDDMF ) ( FSE:4WE ) (“ WeedMD ” or the “ Company ”), a federally l...
-
BEIJING, May 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Infobird Co., Ltd (Nasdaq: IFBD) (“Infobird”), a software-as-a-service (“SaaS”) provider of AI-powered customer engagement solutions in China, today announces that it has filed its annual report on For...
-
HAUPPAUGE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ:FORD), a single source solution provider for the full spectrum of hardware and software product design and engineering services as well as a designer and distributer of carry and protective solutions, today a...
Now Trending
Trending Stock
22.97%Change Percent:
Upstart Holdings Inc. Company Name:
UPST Stock Symbol:
NASDAQ Market:
MENU
UPST Stock
UPST Quote
UPST Short
UPST News
UPST Articles
Get UPST Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
RECENT UPST NEWS
-
Upstart (NASDAQ: UPST) has been a stock market hit since its IPO in December. Shares of the company, which operates an artificial-intelligence-powered consumer-lending platform, have doubled since then -- even after it took part in the recent sell-off of high-growth tech stocks that...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A strong CPI reading spooked investors as they continue to worry about inflation. Let’s look at a few top stock trades as equities took a hit on Wednesday. Top Stock Trades for Tomorrow No. 1: Upstart Holdings ...
-
Wall Street showed no signs of getting calmer on Wednesday morning, with the Nasdaq Composite (NASDAQINDEX: ^IXIC) again taking the brunt of a bearish move that sent the index down more than 1.5% as of 11:15 a.m. EDT. Inflationary pressures are becoming more evident than ever in the...